Thank you for subscribing.

Please check your email to confirm.

Unsubscribe success..

You already subscribed and confirmed.

Please check your email.

You already subscribed.

Please check your email to confirm.

EpimAb: Yet Another Chinese Immuno-oncology Darling of Capital Market
EpimAb: Yet Another Chinese Immuno-oncology Darling of Capital Market
Associated Company
EqualOcean EqualOcean

On 5 June 2019, A Series B funding round of USD 74 million has pushed up EpimAb’s total amount of fundraisings to over USD 100 million. SDIC Fund and Sherpa Healthcare Partner led this round. 

Shanghai-based EpimAb Biotherapeutics is a privately owned biopharmaceutical company focused on creating a pipeline of bispecific antibody therapeutics centred around immuno-oncology.

Bispecific antibody therapeutic is a brand new and innovative method of immunotherapy and EpimAb claims to be a vanguard in this sector.

Currently, the primary therapies used in immunotherapy include immunological checkpoint inhibitors, CAR-T cell therapy, and cancer vaccines. The bispecific antibody is a novel approach and has yet to be tested comprehensively. 

What's more, the company's product is still at a pre-clinical stage. 

Apart from EpimAb, I-Mab Bio (天境生物), Jacobio (加科思), YuceBio (裕策生物) and Shanghai Cell Therapy Group count among the other players in China that are aiming to provide immunotherapy solutions for cancer treatment. 

Led by I-Mab Bio, Chinese immunotherapy companies have attracted significant investor attention due to the overall industrial atmosphere and favorable regulatory environment in 2019.

Enterprise Information

EqualOcean is a leading industry tech media and an investment research company.
CATEGORIES: AI, Research
Last Funding Type
Series C
Number of Employees
200
Number of Funding Rounds
6
Total Funding Amount
26.79M

Enterprise Information

EqualOcean
EqualOcean is a leading industry tech media and an investment research company.
CATEGORIES: AI, Research
Last Funding Type
Series C
Number of Employees
200
Number of Funding Rounds
6
Total Funding Amount
26.79M

Reach the Author!

Ask the author questions about the copied text

MOST READ

THE LATEST

Any Question

EqualOcean is a leading industrial tech media and investment research company that focuses on technological and industrial innovation in China.

We aim to assist Chinese entrepreneurial enterprises to break into the global market and provide overseas investors, VCs, and enterprises with a deeper understanding of China's business environment and to seize opportunities in China.

Join over 800,000 of your peers